Abstract
BACKGROUND: The National Health Service (NHS) intends to introduce a system of electronic transfer of prescription-related information between general practitioners (GPs) and community pharmacies. The NHS Plan describes how this will be achieved. AIM: To gather opinions of patients, GPs, and community pharmacists on the development of a system of electronic transfer of prescription-related information between GPs and community pharmacies. DESIGN OF STUDY: Survey combining interviews, focus groups, and postal questionnaires. SETTING: General practitioners, opinion leaders, computing experts, pharmacists, and patients. Eight hundred members of the public, 200 GPs, and 200 community pharmacists, all living in Scotland. METHOD: Content-setting interviews and focus groups were conducted with purposive samples of relevant groups. Postal questionnaires were developed and sent to random samples of members of the public selected from the electoral roll, GPs, and community pharmacists. RESULTS: The corrected postal response rates were: 69% (patients); 74% (GPs); and 74% (community pharmacists). All three groups were generally supportive of electronic transfer of prescription-related information. Different aspects appealed to each group: patients anticipated improved convenience; GPs, better repeat prescribing; and pharmacists, an enhanced professional role. Security of patient-identifiable information was the main concern. All groups acknowledged potential benefits of a full primary care information system, but GPs and patients had reservations about allowing community pharmacists to access parts of the medical record that did not concern medication. CONCLUSION: Electronic transfer of prescription-related information is likely to be acceptable to all users, but concerns about patient confidentiality and an extended role for pharmacists in prescription management need to be addressed.
Full Text
The Full Text of this article is available as a PDF (82.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bond C., Matheson C., Williams S., Williams P., Donnan P. Repeat prescribing: a role for community pharmacists in controlling and monitoring repeat prescriptions. Br J Gen Pract. 2000 Apr;50(453):271–275. [PMC free article] [PubMed] [Google Scholar]
- Cohen J. E. Universities and tobacco money. BMJ. 2001 Jul 7;323(7303):1–2. doi: 10.1136/bmj.323.7303.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hanlon J. T., Weinberger M., Samsa G. P., Schmader K. E., Uttech K. M., Lewis I. K., Cowper P. A., Landsman P. B., Cohen H. J., Feussner J. R. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996 Apr;100(4):428–437. doi: 10.1016/S0002-9343(97)89519-8. [DOI] [PubMed] [Google Scholar]
- Harris C. M., Dajda R. The scale of repeat prescribing. Br J Gen Pract. 1996 Nov;46(412):649–653. [PMC free article] [PubMed] [Google Scholar]
- Morris A. D., Boyle D. I., MacAlpine R., Emslie-Smith A., Jung R. T., Newton R. W., MacDonald T. M. The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register. DARTS/MEMO Collaboration. BMJ. 1997 Aug 30;315(7107):524–528. doi: 10.1136/bmj.315.7107.524. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zermansky A. G. Who controls repeats? Br J Gen Pract. 1996 Nov;46(412):643–647. [PMC free article] [PubMed] [Google Scholar]